NCT05671315 2023-05-25
A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients
Ruijin Hospital
Phase NA Recruiting
Clinical Trials
3 trialsNCT02982720 2022-02-16
Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron
Hoosier Cancer Research Network
Phase 2 Terminated
NCT00759109 2017-04-07
Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)
Merck Sharp & Dohme LLC
Phase 3 Completed